102 related articles for article (PubMed ID: 30403486)
1. Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan.
Bavo F; Pucci S; Fasoli F; Lammi C; Moretti M; Mucchietto V; Lattuada D; Viani P; De Palma C; Budriesi R; Corradini I; Dowell C; McIntosh JM; Clementi F; Bolchi C; Gotti C; Pallavicini M
J Med Chem; 2018 Dec; 61(23):10531-10544. PubMed ID: 30403486
[TBL] [Abstract][Full Text] [Related]
2. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
3. Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Oh H; Kneisley DL; Eaton B; Lucero L; Gotti C; Clementi F; Whiteaker P; Bolchi C
J Med Chem; 2023 Jan; 66(1):306-332. PubMed ID: 36526469
[TBL] [Abstract][Full Text] [Related]
4. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
5. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
6. Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.
Pucci S; Fasoli F; Moretti M; Benfante R; Di Lascio S; Viani P; Daga A; Gordon TJ; McIntosh M; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2021 Jan; 163():105336. PubMed ID: 33276105
[TBL] [Abstract][Full Text] [Related]
7. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
8. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
9. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
10. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
11. A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors.
McIntosh JM; Plazas PV; Watkins M; Gomez-Casati ME; Olivera BM; Elgoyhen AB
J Biol Chem; 2005 Aug; 280(34):30107-12. PubMed ID: 15983035
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of Nicotine Acetylcholine Receptors Associates with Human Breast Cancer and Mediates Antitumor Activity of αO-Conotoxin GeXIVA.
Sun Z; Zhangsun M; Dong S; Liu Y; Qian J; Zhangsun D; Luo S
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31963558
[TBL] [Abstract][Full Text] [Related]
13. Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors.
Liang J; Tae HS; Xu X; Jiang T; Adams DJ; Yu R
J Med Chem; 2020 Mar; 63(6):2974-2985. PubMed ID: 32101438
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
[TBL] [Abstract][Full Text] [Related]
15. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
[TBL] [Abstract][Full Text] [Related]
16. αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors.
Sun Z; Bao J; Zhangsun M; Dong S; Zhangsun D; Luo S
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32272701
[TBL] [Abstract][Full Text] [Related]
17. Blockers of Nicotinic Acetylcholine Receptors Delay Tumor Growth and Increase Antitumor Activity of Mouse Splenocytes.
Terpinskaya TI; Osipov AV; Balashevich TV; Yanchanka TL; Tamashionik EA; Tsetlin VI; Utkin YN
Dokl Biochem Biophys; 2020 Mar; 491(1):89-92. PubMed ID: 32483759
[TBL] [Abstract][Full Text] [Related]
18. Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants.
Shelukhina I; Spirova E; Kudryavtsev D; Ojomoko L; Werner M; Methfessel C; Hollmann M; Tsetlin V
PLoS One; 2017; 12(8):e0181936. PubMed ID: 28797116
[TBL] [Abstract][Full Text] [Related]
19. Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas.
Medjber K; Freidja ML; Grelet S; Lorenzato M; Maouche K; Nawrocki-Raby B; Birembaut P; Polette M; Tournier JM
Lung Cancer; 2015 Mar; 87(3):258-64. PubMed ID: 25601486
[TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulators of α7* or β2* nicotinic acetylcholine receptors trigger different kinase pathways in mitochondria.
Uspenska K; Lykhmus O; Arias HR; Pons S; Maskos U; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2018 Jun; 99():226-235. PubMed ID: 29704624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
